Insider Transactions in Q1 2023 at Maravai Lifesciences Holdings, Inc. (MRVI)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Carl Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
147,638
+40.21%
|
-
|
|
Mar 15
2023
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,775
+43.45%
|
-
|
|
Mar 15
2023
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,507
+44.29%
|
-
|
|
Mar 15
2023
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,507
+34.77%
|
-
|
|
Mar 15
2023
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
38,386
+38.1%
|
-
|
|
Feb 15
2023
|
Christine Dolan Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,956
-10.41%
|
$29,340
$15.23 P/Share
|
|
Feb 15
2023
|
Kurt Oreshack General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,312
-8.8%
|
$34,680
$15.23 P/Share
|
|
Feb 15
2023
|
Kevin Herde Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,611
-12.26%
|
$39,165
$15.23 P/Share
|
|
Feb 15
2023
|
Carl Hull Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,719
-11.91%
|
$145,785
$15.23 P/Share
|
|
Feb 15
2023
|
Brian Neel Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,312
-12.31%
|
$34,680
$15.23 P/Share
|
|
Jan 22
2023
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,575,170
-3.7%
|
-
|